Funds with similar focus
Fund Name | Location |
AV Capital | Austin, Texas, United States |
Benslie International Ltd | - |
Big Loud Capital | - |
Groupe Arnault | France, Ile-de-France, Paris |
Guosheng-CLSA Investment Fund | - |
Huarun Runxiang Joint | China, Fujian, Hunan |
Iowa First Capital Fund | Cedar Rapids, Iowa, United States |
Keys Asset Management | Luxembourg, Luxembourg |
Maple Capital Advisors | Delhi, India, New Delhi |
Point Nine | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ImVisioN Therapeutics | $3M | 10 Sep 2008 | Lower Saxony |
– Theseus Pharmaceuticals from Boston develops pan-variant kinase inhibitors to treat cancer.
– The company emerged from stealth with the close of a $100m Series B financing.
– The round was led by Foresite Capital with participation from Adage Capital Management, Boxer Capital, Farallon Capital Management, Longitude Capital, Nextech Ventures, Omega Healthcare Investors, Pontifax Venture Capital, Rock Springs Capital, and T. Rowe Price, as well as OrbiMed.
– In conjunction with the financing, Michael Rome, Ph.D., Managing Director of Foresite Capital, has joined the Theseus Board of Directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ImVisioN Therapeutics | $3M | 10 Sep 2008 | Lower Saxony |